ADIPSE assisted Venture Capital funds in undertaking the Intellectual Property audit of Pherecydes Pharma

ADIPSE assisted Venture Capital funds in undertaking the Intellectual Property audit of Pherecydes Pharma.

Pherecydes Pharma a biotechnology company specialized in the research and development of anti-infective therapies based on the use of bacteriophages, raised €8.7M ($10.3M) in a Series B round of financing. The round was led by Go Capital, with participation from Omnes Capital, Fa Dièse and a group of business angels....

read more: Press release